3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Ovarian Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Urogenital Neoplasms
3
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Neuroblastoma
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Interventions
Fluorouracil
14
pembrolizumab
13
Paclitaxel
13
Oxaliplatin
13
Leucovorin
10
Carboplatin
9
Radiotherapy
8
Capecitabine
8
Trastuzumab
7
Nivolumab
7
Drug Therapy
7
Cisplatin
7
Radiation
6
Esophagectomy
6
Taxes
5
Specimen Handling
5
Surgical Procedures, Operative
4
Irinotecan
4
trastuzumab deruxtecan
3
tislelizumab
3
patritumab deruxtecan
3
Radiotherapy, Intensity-Modulated
3
Proton Therapy
3
Immunotherapy
3
Blood Specimen Collection
3
zanidatamab
2
ulixertinib
2
trastuzumab biosimilar HLX02
2
relatlimab
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
aldesleukin
×
90 days
×
Clear all
No trials found.